363166-79-4

Basic information

• Product Name: 2,6-Diisopropylphenylboronic acid
• Synonyms: 2,6-Diisopropylphenylboronic acid;2-(3-isopropylphenyl)propylboronic acid
• CAS NO: 363166-79-4
• Molecular Formula: C₁₂H₁₉BO₂
• Molecular Weight: 206.08906
• Mol File: 363166-79-4.mol
• Article Data: 3

Chemical Properties

• Melting Point: 167-172°C
• Boiling Point: 327.5±52.0 °C(Predicted)
• Appearance: /
• Density: 0.99±0.1 g/cm3(Predicted)
• Storage Temp.: Inert atmosphere,Store in freezer, under -20°C
• PKA: 8.74±0.58(Predicted)
• CAS DataBase Reference: 2,6-Diisopropylphenylboronic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2,6-Diisopropylphenylboronic acid(363166-79-4)
• EPA Substance Registry System: 2,6-Diisopropylphenylboronic acid(363166-79-4)

Safety Data

• WGK Germany: nwg
• Hazardous Substances Data: 363166-79-4(Hazardous Substances Data)

Usage

General Description

2,6-Diisopropylphenylboronic acid is a chemical compound composed of a boronic acid group attached to a 2,6-diisopropylphenyl ring. It is commonly used in organic synthesis as a building block for creating various complex molecules. 2,6-Diisopropylphenylboronic acid has been found to be particularly useful in the field of medicinal chemistry, where it is utilized in the development of pharmaceuticals and as a tool for chemical biology research. Additionally, 2,6-Diisopropylphenylboronic acid has shown potential in cross-coupling reactions, Suzuki-Miyaura coupling, and other organic transformations, making it a valuable reagent for chemical synthesis.

Upstream product

• 121-43-7 Trimethyl borate 
• 57190-17-7 2-bromo-1,3-diisopropylbenzene 
• 688-74-4 boric acid tributyl ester 

Downstream Products

• 1375186-71-2 C₅H₃N(C₅H₃NCH₃)C₅H₃NC₆H₃(CH(CH₃)2)2 
• 1375186-75-6 C₅H₃N(C₅H₃NCH₃)C₅H₃NC₆H₃(CH(CH₃)2)2 
• 2078-54-8 2,6-diisopropylphenol 

Relevant articles and documents

2,6-diisopropyl benzene boric acid derivatives an pharmaceutical use thereof

The invention relates to a type of 2,6-diisopropyl benzene boric acid derivatives and pharmaceutical use thereof. The structure of the derivatives is accordant with a general formula shown in the description, wherein R1 represents -H or -CH(CH3)2. The drugs are sensitive to free radicals, and a large number of free radicals exist at ischemic parts, so that the drugs are capable of releasing diprivan or analogs of diprivan at the ischemic parts, are capable of well protecting ischemic injury and have a neuroprotective effect better than that of diprivan. The derivatives can be applied to the preparation of drugs for treating the ischemic injury.

Structure-based approach to the development of potent and selective inhibitors of dihydrofolate reductase from Cryptosporidium

Cryptosporidiosis is an emerging infectious disease that can be life-threatening in an immune-compromised individual and causes gastrointestinal distress lasting up to 2 weeks in an immune-competent individual. There are few therapeutics available for eff